GlobeNewswire by notified

Correction: Cash flows (CK94) - Totalkredit A/S

Share

To the Nasdaq Copenhagen

Correction: Cash flows (CK94)

Pursuant to s 24 Danish Capital Markets Act, Totalkredit A/S hereby publishes cash flows on open and closed annuity, index-linked and serial loans computed as at January 2023 in the attached file.

Furthermore, the data will be distributed in the usual way through Nasdaq Copenhagen. Data on Nykredit and Totalkredit bonds is also available by ISIN code in Excel format on https://www.nykredit.com/filarkiv/.

For further information about data format and contents, please refer to the Nasdaq website.

Questions may be addressed to Morten Bækmand Nielsen, Head of Investor Relations, tel +45 44 55 15 21.

Yours sincerely
Totalkredit A/S

Attachments

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

Prosafe SE: First-quarter results 20248.5.2024 07:01:01 CEST | Press release

(Figures in brackets refer to the corresponding period last year) 8 May 2024 – Prosafe SE reported EBITDA of USD 7.2 million (negative USD 6.4 million) for the first quarter of 2024. The year-over-year increase in EBITDA was mainly driven by higher utilisation, with four active vessels during the quarter, compared to two active vessels in the same period of 2023. Operations and HSSE Good operating and safety performance on all vessels Q1 2024 utilisation of 56.3% (28.6%), four out of seven vessels operating during the quarterSafe Zephyrus, Safe Notos and Safe Concordia had 100% utilisation in the quarter; Safe Eurus had 95% utilisation due to minor repairs Four out of six options declared for Safe Concordia taking firm period through 9 November 2024, increasing firm backlog by USD 12.7 million Backlog of USD 218 million (USD 316 million) at period-end Q1 financials Revenues of USD 34.0 million (USD 14.3 million) and EBITDA of USD 7.2 million (negative USD 6.4 million)Cash flow from ope

SBM Offshore First Quarter 2024 Trading Update8.5.2024 07:00:27 CEST | Press release

May 8, 2024 Highlights Year-to-date Directional1 revenue of US$871 million, in line with expectationFull year 2024 Directional revenue and Directional EBITDA guidance maintainedCash dividend of US$150 million (equivalent to EUR0.7651 per ordinary share) approvedShare repurchase program of EUR65 million on track 20.7% completed2FPSO Sepetiba producing and on hire; FPSO Prosperity at full production capacityFPSO Jaguar contract award confirmed in April 2024, growing the backlog MoU with Technip Energies to create Floating Offshore Wind JV, EkWiL Øivind Tangen, CEO of SBM Offshore, commented: “We have delivered good results this quarter in line with expectations and we maintain our full year guidance. We are pleased to have been awarded contracts in April for the construction and installation of ExxonMobil Guyana’s FPSO Jaguar as part of the Whiptail development. This significant award is the fifth FPSO project for SBM Offshore in Guyana. It will be our first based on a sale and operate m

Pharming Group reports first quarter 2024 financial results and provides business update8.5.2024 07:00:00 CEST | Press release

First quarter 2024 revenues increased by 31% to US$55.6 million, compared to the first quarter 2023, driven by the U.S. commercial launch of Joenja® and revenue growth of RUCONEST®RUCONEST® revenues increased by 8% to US$46.0 million, compared to the first quarter 2023Joenja® (leniolisib) revenue of US$9.6 million, a 21% increase compared to the fourth quarter of 2023On track for 2024 total revenue guidance of US$280 million - US$295 million (14 - 20% growth)Overall cash and marketable securities of US$203.5 million at the end of the quarterPharming to host a conference call today at 13:30 CEST (7:30 am EDT) Leiden, the Netherlands, May 8, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM / Nasdaq: PHAR) presents its preliminary (unaudited) financial report for the three months ended March 31, 2024. Chief Executive Officer, Sijmen de Vries commented: “Pharming delivered a strong first quarter, increasing quarterly revenues by 31% year-over-year to US$55

TGS Announces Q1 2024 Results8.5.2024 07:00:00 CEST | Press release

OSLO, Norway (8 May 2024) - TGS today reported interim financial results for Q1 2024. The quarter reflected a strong development in multi-client late sales and high POC early sales rate, resulting in solid profitability in POC financials. Financial highlights: POC revenues (1) were USD 227 million compared to USD 229 million in Q1 2023 POC EBITDA of USD 143 million versus USD 119 million in Q1 2023POC operating result was USD 40 million compared to USD 25 million in Q1 2023 Contract inflow of USD 140 million during Q1 2024 compared to USD 248 million in Q1 2023 – total POC order backlog including Acquisition of USD 459 millionStrong development in multi-client late sales, up 58% year-over-yearDividend of USD 0.14 (NOK 1.52) per share to be paid in Q2 2024 IFRS revenues (1) of USD 152 million versus USD 173 million in Q1 2023IFRS EPS (fully diluted) of USD -0.13 versus USD -0.07 in Q1 2023 “We are pleased to see late sales of completed multi-client data in Q1 2024 showing good progress

DNO Reports Strong First Quarter Results, Steps Up North Sea Activity8.5.2024 07:00:00 CEST | Press release

Oslo, 8 May 2024 – DNO ASA, the Norwegian oil and gas operator, today reported first quarter 2024 operating profit of USD 61 million, 61 percent higher than the previous quarter, on the back of revenues totaling USD 183 million. Free cash flow at USD 44 million was up 31 percent from the fourth quarter of 2023. Net production climbed 14 percent quarter-on-quarter and averaged 74,800 barrels of oil equivalent per day (boepd) in the first three months of 2024, to which the Kurdistan region of Iraq contributed 57,200 boepd, the North Sea 14,200 boepd and West Africa 3,300 boepd. Production from the flagship Tawke license (DNO 75 percent and operator) in Kurdistan has now largely been restored after the March 2023 Iraq-Türkiye Pipeline shutdown as the Company continues to use road tankers to sell its oil to local trading companies on a cash and carry basis with payments deposited into Company accounts in international banks. DNO recently negotiated higher wellhead prices for such sales, ra

HiddenA line styled icon from Orion Icon Library.Eye